Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

CYCLOOXYGENASES 1 AND 2

Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,763

Cyclooxygenase in biology and disease

Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R., Simon, L. S., Putte, L., & Lipsky, P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,606

Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2

Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,973

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,922

A second endogenous cannabinoid that modulates long-term potentiation

Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310

Prostaglandin synthase 2

Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,200

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop‐Bailey, D., Croxtall, J. D., & Willoughby, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2046 · Cited by 1,035

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavón, F. J., Serrano, A., Selley, D. E., Parsons, L. H., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.129 · Cited by 954

ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS

Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 829

Multiple Functions of Endocannabinoid Signaling in the Brain

Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630

Why there are two cyclooxygenase isozymes

Smith, W. L., & Langenbach, R. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13271 · Cited by 612

Cannabinoid receptors and their ligands

Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0341 · Cited by 577

Enzymatic pathways that regulate endocannabinoid signaling in the nervous system

Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529

Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice

Gao, Y., Vasilyev, D. V., Goncalves, M. B., Howell, F. V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M.-Y., Strassle, B. W., Lu, P., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5693-09.2010 · Cited by 473

When does acute pain become chronic?

Voscopoulos, C., & Lema, M. (2010) · British Journal of Anaesthesia · doi:10.1093/bja/aeq323 · Cited by 473

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

Julien, B., Grenard, P., Teixeira-Clerc, F., Nhieu, J. T. V., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470

Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Hillard, C. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.130 · Cited by 449

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.130 · Cited by 453

Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides

Kozak, K. R., Crews, B. C., Morrow, J. D., Wang, L.-H., Ma, Y. H., Weinander, R., Jakobsson, P.-J., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206788200 · Cited by 368

The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation

Marzo, V. D. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.010 · Cited by 381

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand

SUGIURA, T., KISHIMOTO, S., OKA, S., & Gokoh, M. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.03.003 · Cited by 374

The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications

Lambert, D. M., & Fowler, C. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058183t · Cited by 354

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0356 · Cited by 351

Cultured Rat Microglial Cells Synthesize the Endocannabinoid 2-Arachidonylglycerol, Which Increases Proliferation via a CB2 Receptor-Dependent Mechanism

Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336

Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways

Rouzer, C. A., & Marnett, L. J. (2011) · Chemical Reviews · doi:10.1021/cr2002799 · Cited by 309

Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes

Manzanares, J., Julian, M., & Carrascosa, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906778019527 · Cited by 287

Sensory and Signaling Mechanisms of Bradykinin, Eicosanoids, Platelet-Activating Factor, and Nitric Oxide in Peripheral Nociceptors

Pethö, G., & Reeh, P. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00048.2010 · Cited by 299

Cannabinoid Receptors and Endocannabinoids: Evidence for New Players

Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1007/bf02854900 · Cited by 303

Endocannabinoid signaling in microglial cells

Stella, N. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.037 · Cited by 278

Mechanism of Free Radical Oxygenation of Polyunsaturated Fatty Acids by Cyclooxygenases

Rouzer, C. A., & Marnett, L. J. (2003) · Chemical Reviews · doi:10.1021/cr000068x · Cited by 266

Parsing the players: 2‐arachidonoylglycerol synthesis and degradation in the CNS

Murataeva, N., Straiker, A. J., & Mackie, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12411 · Cited by 275

COX-2-derived endocannabinoid metabolites as novel inflammatory mediators

Alhouayek, M., & Muccioli, G. G. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.001 · Cited by 261

An introduction to the endocannabinoid system: from the early to the latest concepts

PETROCELLIS, L. D., & Marzo, V. D. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.013 · Cited by 260

Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone

Orlando, B. J., & Malkowski, M. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.725713 · Cited by 268

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor

Klegeris, A., Bissonnette, C. J., & McGeer, P. L. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705304 · Cited by 251

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites

Turcotte, C., Chouinard, F., Lefebvre, J. S., & Flamand, N. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0115-021r · Cited by 258

Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus

Kim, J., & Alger, B. E. (2004) · Nature Neuroscience · doi:10.1038/nn1262 · Cited by 239

Cyclooxygenase-2 Biology

Clària, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454054 · Cited by 238

The endocannabinoid system as a target for novel anxiolytic drugs

Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233

Electrospray ionization and tandem mass spectrometry of eicosanoids

Murphy, R. C., Barkley, R. M., Berry, K. A. Z., Hankin, J. A., Harrison, K. A., Johnson, C. A., Krank, J., McAnoy, A. M., Uhlson, C. L., & Zarini, S. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.04.042 · Cited by 231

2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain

Baggelaar, M. P., Maccarrone, M., & van der Stelt, M. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.05.002 · Cited by 224

Effects of cannabinoids on LPS‐stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids

Chang, Y., Lee, S. T., & Lin, W. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1103 · Cited by 219

Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy

Romano, M., & Clària, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0053rev · Cited by 222

Cannabinoid signaling in glial cells

Stella, N. (2004) · Glia · doi:10.1002/glia.20084 · Cited by 226

Cyclooxygenase enzymes: catalysis and inhibition

Kurumbail, R. G. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(01)00277-9 · Cited by 212

Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs

Rouzer, C. A., & Marnett, L. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00215 · Cited by 206

Cyclooxygenase-2 in synaptic signaling

Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195

Paracetamol – An old drug with new mechanisms of action

Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190

Cannabis, cannabinoids and reproduction

Park, B., McPartland, J. M., & Glass, M. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.007 · Cited by 191

15-Lipoxygenase Metabolism of 2-Arachidonylglycerol

Kozak, K. R., Gupta, R. A., Moody, J. S., Ji, C., Boeglin, W. E., DuBois, R. N., Brash, A. R., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201084200 · Cited by 160

Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus

Hashimotodani, Y., Ohno‐Shosaku, T., & Kano, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4159-06.2007 · Cited by 186

(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2

Duggan, K. C., Hermanson, D. J., Musee, J., Prusakiewicz, J. J., Scheib, J. L., Carter, B. D., Banerjee, S., Oates, J. A., & Marnett, L. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.663 · Cited by 184

Eicosanoid signalling pathways in the heart

Jenkins, C. M., Cedars, A. M., & Gross, R. W. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn346 · Cited by 182

The Biosynthesis of Enzymatically Oxidized Lipids

Hajeyah, A. A., Griffiths, W. J., Wang, Y., Finch, A. J., & O’Donnell, V. B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.591819 · Cited by 198

Endocannabinoids in the retina: From marijuana to neuroprotection

Yazulla, S. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.07.002 · Cited by 188

Cannabinoid Mechanisms of Pain Suppression

Walker, J. M., & Hohmann, A. G. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 177

The enzymology of prostaglandin endoperoxide H synthases-1 and -2

Smith, W. L., & Song, I. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00025-4 · Cited by 173

Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells

Muccioli, G. G., Xu, C., Odah, E., Cudaback, E., Cisneros, J. A., Lambert, D. M., López-Rodríguez, M. L., Bajjalieh, S., & Stella, N. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4830-06.2007 · Cited by 175

Oxidative metabolism of endocannabinoids

Kozak, K. R., & Marnett, L. J. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0359 · Cited by 170

Blockade of 2-Arachidonoylglycerol Hydrolysis by Selective Monoacylglycerol Lipase Inhibitor 4-Nitrophenyl 4-(Dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances Retrograde Endocannabinoid Signaling

Pan, B., Wang, W., Long, J. Z., Sun, D., Hillard, C. J., Cravatt, B. F., & Liu, Q.-S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158162 · Cited by 164

Structural Basis of Fatty Acid Substrate Binding to Cyclooxygenase-2

Vecchio, A. J., Simmons, D. M., & Malkowski, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119867 · Cited by 165

LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis

Reed, A., Ichu, T.-A., Milosevich, N., Melillo, B. N., Schafroth, M. A., Otsuka, Y., Scampavia, L. D., Spicer, T., & Cravatt, B. F. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00317 · Cited by 169

Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB 1 receptor‐dependent G‐protein activation in rat cerebellar membranes

Savinainen, J. R., Järvinen, T., Laine, K., & Laitinen, J. T. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704297 · Cited by 163

Characterization of the Sulfhydryl-Sensitive Site in the Enzyme Responsible for Hydrolysis of 2- Arachidonoyl-Glycerol in Rat Cerebellar Membranes

Saario, S. M., Salo‐Ahen, O. M. H., Nevalainen, T., Poso, A., Laitinen, J. T., Järvinen, T., & Niemi, R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.013 · Cited by 158

CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids

McAllister, S. D., & Glass, M. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0344 · Cited by 163

Monoacylglycerols Activate TRPV1 – A Link between Phospholipase C and TRPV1

Zygmunt, P. M., Ermund, A., Movahed, P., Andersson, D. A., Simonsen, C., Jönsson, B., Blomgren, A., Birnir, B., Bevan, S., Eschalier, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081618 · Cited by 157

Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa

Ruhaak, L. R., Felth, J., Karlsson, P. C., Rafter, J. J., Verpoorte, R., & Bohlin, L. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.774 · Cited by 154

Prostaglandin E 2 glycerol ester, an endogenous COX‐2 metabolite of 2‐arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity

Hu, S. S., Bradshaw, H. B., Chen, J. S., Tan, B., & Walker, J. M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.33 · Cited by 151

Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke

Ye, Y. N. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi012 · Cited by 150

Cannabinoid Receptors and Endocannabinoids: Evidence for New Players

Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1208/aapsj080234 · Cited by 149

Alterations of Endocannabinoid Signaling, Synaptic Plasticity, Learning, and Memory in Monoacylglycerol Lipase Knock-out Mice

Pan, B., Wang, W., Zhong, P., Blankman, J. L., Cravatt, B. F., & Liu, Q.-S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2075-11.2011 · Cited by 160

Endogenous cannabinoids revisited: A biochemistry perspective

Fonseca, B. M., Costa, M. A., Almada, M., Correia‐da‐Silva, G., & Teixeira, N. A. A. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.02.002 · Cited by 153

Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways

Serhan, C. N., & Oliw, E. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13375 · Cited by 146

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

Jhaveri, M. D., Richardson, D. S., & Chapman, V. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707433 · Cited by 147

Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024)

Woodward, D. F., Krauss, A. H. ‐., Chen, J., Liang, Y., Li, C., Protzman, C. E., Bogardus, A. M., Chen, R., Kedzie, K. M., Krauss, H. A., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047837 · Cited by 143

Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerol

Szabó, B., Urbanski, M. J., Bisogno, T., Marzo, V. D., Mendiguren, A., Baer, W. U., & Freiman, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.119362 · Cited by 142

Phospholipid-esterified Eicosanoids Are Generated in Agonist-activated Human Platelets and Enhance Tissue Factor-dependent Thrombin Generation

Thomas, C. P., Morgan, L. T., Maskrey, B. H., Murphy, R. C., Kühn, H., Hazen, S. L., Goodall, A. H., Hamali, H. A., Collins, P. W., & O’Donnell, V. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078428 · Cited by 140

Differential Sensitivity and Mechanism of Inhibition of COX-2 Oxygenation of Arachidonic Acid and 2-Arachidonoylglycerol by Ibuprofen and Mefenamic Acid

Prusakiewicz, J. J., Duggan, K. C., Rouzer, C. A., & Marnett, L. J. (2009) · Biochemistry · doi:10.1021/bi900999z · Cited by 139

Metabolism of Prostaglandin Glycerol Esters and Prostaglandin Ethanolamides in Vitro and in Vivo

Kozak, K. R., Crews, B. C., Ray, J. L., Tai, H., Morrow, J. D., & Marnett, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105854200 · Cited by 139

Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids

Astarita, G., Kendall, A. C., Dennis, E. A., & Nicolaou, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.012 · Cited by 140

Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation

Wang, M., Hill, M. N., Zhang, L., Gorzalka, B. B., Hillard, C. J., & Alger, B. E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111409606 · Cited by 137

The Structure of Mammalian Cyclooxygenases

Garavito, R. M., & Mulichak, A. M. (2003) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.32.110601.141906 · Cited by 137

Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation

Zhang, J., & Chen, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800524200 · Cited by 136

Endocannabinoid system: Role in depression, reward and pain control (Review)

Huang, W., Chen, W., & Zhang, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5585 · Cited by 139

The complications of promiscuity: endocannabinoid action and metabolism

Alexander, S. P. H., & Kendall, D. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707456 · Cited by 136

More surprises lying ahead. The endocannabinoids keep us guessing

Piomelli, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.026 · Cited by 128

New insights into COX-2 biology and inhibition

Patrignani, P., Tacconelli, S., Sciulli, M. G., & Capone, M. L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.024 · Cited by 131

Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors

van Egmond, N., Straub, V. M., & van der Stelt, M. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-112741 · Cited by 137

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

Hermanson, D. J., Hartley, N. D., Gamble-George, J., Brown, N., Shonesy, B. C., Kingsley, P. J., Colbran, R. J., Reese, J., Marnett, L. J., & Patel, S. (2013) · Nature Neuroscience · doi:10.1038/nn.3480 · Cited by 126

Endocannabinoid System Modulates Relapse to Methamphetamine Seeking: Possible Mediation by the Arachidonic Acid Cascade

Anggadiredja, K., Nakamichi, M., Hiranita, T., Tanaka, H., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300454 · Cited by 125

COX-2 as a multifunctional neuronal modulator

Bazan, N. G. (2001) · Nature Medicine · doi:10.1038/86477 · Cited by 125

The eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase pathways

Smith, W. L., & Murphy, R. C. (2008) · Elsevier eBooks · doi:10.1016/b978-044453219-0.50014-3 · Cited by 123

Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation

Hermanson, D. J., Gamble‐George, J., Marnett, L. J., & Patel, S. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.006 · Cited by 121

Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation

Pálóczi, J., Varga, Z. V., Hasko, G., & Pacher, P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7144 · Cited by 129

Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants

Gorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 120

Modulation of the serotonin system by endocannabinoid signaling

Haj‐Dahmane, S., & Shen, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.016 · Cited by 126

Endocannabinoids and neurodegenerative diseases

Micale, V., Mazzola, C., & Drago, F. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.008 · Cited by 119

Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids

Rouzer, C. A., & Marnett, L. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800005200 · Cited by 118

Cyclooxygenase-2-specific Inhibitor Improves Functional Outcomes, Provides Neuroprotection, and Reduces Inflammation in a Rat Model of Traumatic Brain Injury

Gopez, J., Yue, H., Vasudevan, R., Malik, A. S., Fogelsanger, L. N., Lewis, S. A., Panikashvili, D., Shohami, E., Jansen, S. A., Narayan, R. K., et al. (2005) · Neurosurgery · doi:10.1227/01.neu.0000154060.14900.8f · Cited by 113

The glyceryl ester of prostaglandin E 2 mobilizes calcium and activates signal transduction in RAW264.7 cells

Nirodi, C. S., Crews, B. C., Kozak, K. R., Morrow, J. D., & Marnett, L. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303950101 · Cited by 113

Postictal hypoperfusion/hypoxia provides the foundation for a unified theory of seizure‐induced brain abnormalities and behavioral dysfunction

Farrell, J. S., Colangeli, R., Wolff, M. D., Wall, A. K., Phillips, T. J., George, A. G., Federico, P., & Teskey, G. C. (2017) · Epilepsia · doi:10.1111/epi.13827 · Cited by 112

A review of pharmacological and pharmacokinetic properties of Forsythiaside A

Gong, L., Wang, C., Zhou, H., Ma, C., Zhang, Y., Peng, C. Y., & Li, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105690 · Cited by 110

Cannabinoids and the Brain

Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110

The Role of Brain Cyclooxygenase-2 (Cox-2) Beyond Neuroinflammation: Neuronal Homeostasis in Memory and Anxiety

Ramos, D. L., & Ballaz, S. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02087-x · Cited by 108

Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids

Hanuš, L. O. (2008) · Medicinal Research Reviews · doi:10.1002/med.20135 · Cited by 117

Lipidomic analysis of endocannabinoid metabolism in biological samples

Astarita, G., & Piomelli, D. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.01.008 · Cited by 108

Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain

Strauss, K. I. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.09.011 · Cited by 105

Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids

Rouzer, C. A., & Marnett, L. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800005200 · Cited by 118

Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain

Morgan, A., Kingsley, P. J., Mitchener, M. M., Altemus, M., Patrick, T. A., Gaulden, A. D., Marnett, L. J., & Patel, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00499 · Cited by 37

Assay of Endocannabinoid Oxidation by Cyclooxygenase-2

Kudalkar, S. N., Kingsley, P. J., & Marnett, L. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3539-0_21 · Cited by 9

Endocannabinoid oxygenation by prostaglandin H synthase-2: Chemistry and biology

Rouzer, C. A., & Marnett, L. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110870 · Cited by 1

Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol

Kozak, K. R., Prusakiewicz, J. J., Rowlinson, S. W., Schneider, C. G., & Marnett, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104467200 · Cited by 66